BCL6 and neoplasm: Tumors from mice treated with FX-1 also displayed reduced cell proliferation and metastasis (Fig. 7H, I), suggesting that targeting BCL6 reduces this tumor growth mainly via induction of cell cycle arrest, which is consistent with the previous findings [31, 32].